期刊文献+

高危型人乳头瘤病毒阴性宫颈癌患者临床病理特征分析 被引量:11

Clinical and Pathological Features of High-risk HPV-negative Cervical Cancer
下载PDF
导出
摘要 背景宫颈癌是女性常见的生殖道恶性肿瘤。高危型人乳头瘤病毒(HPV)的持续感染是其主要病因。然而临床研究发现,有相当一部分宫颈癌患者高危型HPV检测结果为阴性,且这类患者术后复发风险、肿瘤细胞侵袭以及转移风险均增加。目的分析高危型HPV阴性宫颈癌患者的临床病理特征。方法2003-2016年浙江大学医学院附属妇产科医院住院治疗、临床病理资料完整且术前有HPV-HC2检测结果的宫颈癌患者共1 416例,经第2代杂交捕获技术(HC-Ⅱ)检测高危型HPV阳性宫颈癌患者1 296例,高危型HPV阴性宫颈癌患者120例。调取120例高危型HPV阴性宫颈癌组织石蜡标本,采用实时荧光聚合酶链式反应(PCR)法对高危型HPV进行再检测,获取高危型HPV真阴性患者为高危型HPV阴性组。从1 296例高危型HPV阳性宫颈癌患者中以随机数字表法选取与高危型HPV真阴性组等量的患者为高危型HPV阳性组。收集两组患者的发病年龄、初次生育年龄、分娩次数、临床分期及病理类型等。结果1 416例宫颈癌患者中,HC-Ⅱ法检测高危型HPV阴性120例,阴性率为8.5%。实时荧光PCR法显示,高危型HPV仍为阴性89例,阴性率为6.3%,两次检测符合率为74.2%(89/120)。高危型HPV阴性组患者发病年龄28~75岁,平均发病年龄(45.2±4.2)岁;高危型HPV阳性组患者发病年龄21~78岁,平均发病年龄(46.3±5.1)岁。两组患者平均发病年龄、各发病年龄构成、初次生育年龄、分娩次数、临床分期比较,差异均无统计学意义(P>0.05)。两组患者病理类型比较,差异有统计学意义(χ^2=22.062,P=0.001)。结论采用实时荧光PCR法检测宫颈癌组织石蜡样本中的高危型HPV是一种高敏感度的检测方法。与高危型HPV阳性宫颈癌相比,高危型HPV阴性宫颈癌发病率不高,但其腺癌、腺鳞癌及其他少见类型癌的比例高于高危型HPV阳性的宫颈癌患者。 Background Cervical cancer is a common malignant tumor of the female reproductive system,which mainly caused by persistent infection of high-risk human papillomavirus(HPV).However,clinical studies found that a considerable number of cervical cancer patients are high-risk HPV-negative,and such patients have increased risks of postoperative recurrence,cancer cell invasion and metastasis.Objective To describe the clinical and pathological features of high-risk HPV-negative cervical cancer patients.Methods This analysis was performed on 1 416 cervical cancer inpatients with complete clinicopathological data recruited from Women’s Hospital,School of Medicine Zhejiang University during 2003 to 2016.Among them,1 296 were high-risk HPV-positive,and 120 were high-risk HPV-negative showed by preoperative Hybrid Capture II HPV Test(HCⅡ).Paraffin-embedded cervical cancer samples of high-risk HPV-negative patients were reexamined by real-time PCR,and those were truly negative for high-risk HPV were assigned to high-risk HPV-negative group,and were compared with the same number of high-risk HPV-positive patients randomly selected from the 1 296 cases.Data about age of onset,age at first birth,number of births,clinical stage,and pathological type of the two groups were collected.Results The rate of high-risk HPV-negative detected by HCⅡ was 8.5%(120/1 416).And of these 120 cases,89 were found to be truly negative for high-risk HPV by real-time PCR,achieving a rate of truly high-risk HPV-negative of 6.3%.The coincidence rate of the two tests was 74.2%(89/120).The mean onset age for high-risk HPV-negative,and high-riskHPV-positive patients was(45.2±4.2)years(range 28-75),(46.3±5.1)years(range 21-78),respectively.No significant differences were observed in terms of mean age of onset,distribution of onset age,distributions of age at first birth,number of births,and clinical stage between the two groups(P>0.05),but there was significant difference in pathological type distribution between them(χ^2=22.062,P=0.001).Conclusion Real-time high-risk HPV test is highly sensitive in detecting high-risk HPV DNA.Compared with high-risk HPV-positive cervical cancer,although the overall incidence rate of HPV-negative cervical cancer is not high,the incidence rates of adenocarcinoma,adenosquamous carcinoma and other rare histologic subtypes are higher.
作者 陈文增 陈亚侠 CHEN Wenzeng;CHEN Yaxia(Women's Hospital,School of Medicine Zhejiang University,Hangzhou 310006,China;Tongde Hospital of Zhejiang Province,Hangzhou 310012,China)
出处 《中国全科医学》 CAS 北大核心 2019年第26期3179-3183,共5页 Chinese General Practice
关键词 宫颈肿瘤 人乳头瘤病毒 病理状态 体征和症状 聚合酶链反应 Uterine cervical neoplasms Human papillomavirus Pathological conditions,sign and symptom Polymerase chain reaction
  • 相关文献

参考文献4

二级参考文献77

  • 1吴玉萍,陈裕隆,李隆玉,梁增文,张雁玲.宫颈癌患者人乳头瘤病毒(HPV)主要型别及其感染研究[J].病毒学报,2005,21(4):269-273. 被引量:56
  • 2赵健,杨英捷,廖秦平.导流杂交基因芯片技术在人乳头状瘤病毒感染分型检测中的临床应用[J].中华检验医学杂志,2006,29(12):1148-1151. 被引量:81
  • 3Walboomers JM, Jaclbs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer world-wide [J]. J Pathol, 1999, 189(1): 12-9.
  • 4Munoz N, Bosch FX, de Sanjose S, et al. The causal link between human papiUomavirus and invasive cancer:a population-based case-control study in Colombia and Spain[J]. Int J Cancer, 1992, 52 (5): 743-9.
  • 5Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldswide: a meta-analysis [ J ]. Br J Cancer, 2003, 88: 63-73.
  • 6Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer[J]. N Engl J Med, 2003, 348: 518-27.
  • 7Prado JC, Calleja-Macias IE, Bernard HU, et al. Worldwide genomic diversity of the human papillomaviruses-53, 56 and 66, a group of high-risk HPVs unrelated to HPV-16 and HPV-18 [J]. Virology, 2005, 340(1): 95-104.
  • 8Wheeler CM, Hunt WC, Joste NE, et al. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States [J]. J Natl Cancer hast, 2009, 101 (7): 475-7.
  • 9鲍彦平,李霓,王鹤,乔友林.中国妇女子宫颈人乳头瘤病毒型别分布的Meta分析[J].中华流行病学杂志,2007,28(10):941-946. 被引量:79
  • 10Kitchener HC, Almonte M, Thomson C, et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC):a randomised controlled trial. Lancet Onco1,2009,10:672-682.

共引文献39

同被引文献148

引证文献11

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部